Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ivermectin B1a monosaccharide is produced by selective hydrolysis of the terminal saccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity. This compound has been used as a probe to detect some types of ivermectin resistance.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 35 days | $ 120.00 | |
10 mg | 35 days | $ 223.00 |
Description | Ivermectin B1a monosaccharide is produced by selective hydrolysis of the terminal saccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity. This compound has been used as a probe to detect some types of ivermectin resistance. |
Molecular Weight | 730.936 |
Formula | C41H62O11 |
CAS No. | 71837-27-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
Methanol: Soluble
DMF: Soluble
Ethanol: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ivermectin B1a monosaccharide 71837-27-9 Ivermectin B-1a monosaccharide inhibitor inhibit